Results 211 to 220 of about 4,991 (245)
Some of the next articles are maybe not open access.
Nitrendipine–Induced Gingival Overgrowth in Dogs
Journal of Periodontology, 1989This study assessed the development of gingival overgrowth in dogs given nitrendipine, a new antihypertensive dihydropyridine. Nine male Beagle dogs with established plaque and gingivitis were used. Following a baseline examination, which involved assessment of plaque, gingivitis, and gingival enlargement, six dogs (test) received nitrendipine twice ...
L, Heijl, Y, Sundin
openaire +2 more sources
Cyclosporin‐induced gingival overgrowth in children
International Journal of Paediatric Dentistry, 2005SummaryCyclosporin is a potent immunosuppressant drug commonly used to prevent organ transplant rejection. In recent years, there has been a widening of its therapeutic use and an increase in the number of patients undergoing transplantation. Gingival overgrowth is one of several oral side‐effects of cyclosporin, with a quoted prevalence of between 8 ...
G, Wright, R R, Welbury, M T, Hosey
openaire +2 more sources
The management of drug‐induced gingival overgrowth
Journal of Clinical Periodontology, 2006AbstractObjectives: This review critically evaluates the different therapies that are available to manage drug‐induced overgrowth (DIGO).Material and Methods: This review is based on literature identified using the online databases MEDLINE and PUB MED.
M, Mavrogiannis +3 more
openaire +2 more sources
Iatrogenic Gingival Overgrowth in Cardiac Transplantation
Journal of Periodontology, 1995It is well established that both cyclosporin and nifedipine are associated with gingival overgrowth. Although both drugs are widely used in the management of organ transplant patients, there is little information on the prevalence and severity of this unwanted effect in cardiac transplant patients. This study evaluated the gingival health of 94 dentate
J M, Thomason +6 more
openaire +2 more sources
A clinical review of drug‐induced gingival overgrowths
Australian Dental Journal, 1999AbstractThere is an increasing number of medications associated with gingival overgrowth. These medications are used to treat a number of common conditions in the Australian population and as such denitsts can expect to manage a number of patients with medication‐related gingival overgrowth.
Marshall, R. I., Bartold, P. M.
openaire +5 more sources
[The causes of gingival overgrowth].
Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2000Gingival overgrowth includes a series of diseases with many clinical appearances. The pathological mechanisms being obscure there were used many terms for defining it. Thus, "gingival hyperplasia" and "gingival hypertrophy" were the definitions used to define this pathology.
M, Costuleanu +4 more
openaire +1 more source
Calcium channel blockers and gingival overgrowth
British Dental Journal, 1991Calcium channel blockers are widely used in medical practice for the management of cardiovascular disorders. Of concern to the dental practitioner is the effect of these drugs on the gingival tissues. All classes of calcium channel blockers have been implicated in causing gingival overgrowth.
openaire +2 more sources
Gingival overgrowth and drug association
Journal of Academy of Medical Sciences, 2012Drugs used locally or systemically induce several micro- and macroscopic tissue alterations. However, nearly 20 drugs have been reported so far in the literature, having association with the gingival enlargement. Many systemic diseases have their limited therapeutic options and such drugs or their metabolites have adverse influence on different systems/
M.B. Mishra, Z.Y. Khan, Shanu Mishra
openaire +1 more source